QualityStocks News Alert
  The QualityStocks Daily Newsletter for Tuesday May 26th, 2009 Blog  |  Video  |  Market Basics  |  Quotes & News  |  Clients  |  Partners  |  About Us  |  Contact Us

Today's Top 3 Investment Newsletters

1.

Penny Stock Chaser (USCN)

2.

Wall Street News Alert (MAPP)

3.

Wall Street Resources (CXTO)


The QualityStocks Daily

Finish Line Inc. (FINL)

Today we are reporting on Finish Line Inc. (FINL), here at the QualityStocks Daily Newsletter.

Finish Line Inc. is an Indianapolis, Indiana headquartered specialty retailer. Their corporate focus is to provide the best selection of sport inspired footwear, apparel, and accessories. They are a corporation whose commitment is to produce products to match a person's chosen Sport, Life, and Style. At Finish Line, Sport is the foundation for everything the Company thinks and does. The Company trades on NASDAQ.

Founded in 1976, Finish Line Inc. is one of the largest mall-based specialty retailers operating under the Finish Line and Man Alive brand names. The Company serves their customers through 685 Finish Line stores in 47 states. They also serve their customers through their 81 Man Alive stores in 19 states. In addition, they serve their broad customer base through their online presence. Finish Line Inc. sells their merchandise through their Web sites, www.finishline.com and www.manalive.com, as well as through catalogs.

The Finish Line stores offer men's, women's, and children's athletic, lifestyle, outdoor footwear, and soft goods.  The soft goods lines consist of jackets, caps, tops, pants, and shorts. It also consists of wind wear, running wear, warm-ups, fleece, fitness wear, and sport-casual wear. They also include licensed apparel and caps, socks, athletic bags, backpacks, sunglasses, watches, and shoe-care products. The Company offers footwear for basketball, running, sport style, fitness, and outdoor uses. Their Man Alive stores sell jeans, polo shirts, knit tops, jean shorts, and graphic t-shirts for men and women.

On April 27, 2009, The Finish Line, Inc. announced that their Board of Directors declared a quarterly cash dividend of $0.03 per share of Class A and Class B common stock. The quarterly cash dividend is payable on June 15, 2009 to shareholders of record on May 29, 2009.

Finish Line Inc. (FINL) closed at $6.91, which was up $0.20, or 2.98 percent. Volume was 2,368,151 shares. Their 3-month average volume is 824,456.

Hydromer Inc. (HYDI)

Today we are highlighting Hydromer Inc. (HYDI), here at the QualityStocks Daily Newsletter.

Hydromer, Inc. is a technology-based company involved in the research and development, manufacture and commercialization of specialized polymer and hydrogel products. These are for medical device, pharmaceutical, animal health, cosmetic, personal care, and industrial uses. Headquartered in Branchburg, New Jersey, Hydromer Inc. lists on the OTCBB. Their clients include CR Bard, Pfizer - Schick Razor Division, Johnson & Johnson - Cordis Corporation division, Circon-Surgitek, a subsidiary of MAXXIM, Tyco International/The Tyco Healthcare Companies, and L'Oreal, among many others.

Hydromer owns patents for Hydromer coatings, which find use in materials, such as polyurethane, polyvinyl chloride, and silicone elastomers, as well as ceramics, and metals. The Company also has patents for permanent anti-fog materials, hydrophilic polyurethane foams, hydrophilic polyurethane blends, hydrophilic polyvinylbutyral alloys, various biocompatible hydrogels, and an anti-bacterial medical material. Their OEM medical device portfolio consists of bipolar coagulation probes, placement catheters, biliary stents, jejunal and enteral feeding accessories, guidewires, biofeedback devices for fecal and urinary incontinence, and other endoscopic accessories.

The Company also sells anti-fog/condensation control, an optical coating that prevents the accumulation of vision-obscuring condensation under high humidity conditions. This is for manufacturers of greenhouse panels, refrigerator freezer doors, industrial and medical safety and swim goggles, aircraft windows, automotive headlight assemblies, and gauge and meter manufacturers.

In addition, Hydromer Inc. offers Aquadapt®, skin adhesive and wound dressing gels. They also sell their Dermaseal®, a film-forming hydrogel technology used by cosmetic companies. This is in addition to a host of other products that the Company markets.

On March 5, 2009, Hydromer Inc. announced that they entered into a new Availability and Supply Agreement. The new agreement, with some modifications over a previously cancelled agreement, provides Hydromer's customer, a large New Jersey device manufacturer, to a continued supply and support of two of Hydromer's proprietary lubricious coatings. This is for a fee of $35,000 per month on a non-exclusive basis. This agreement, effective January 1, 2009 has guaranteed fifteen-month duration and provides for a 90-day cancellation notice by either party after the first twelve months.

Hydromer Inc. (HYDI) closed Tuesday's session at $0.79 up $0.41 or 107.89 percent. Volume was 100 shares for a 3-month average volume of 1,077.

Texas Sweet Crude Oil Corp. (TXSC)

Today we are highlighting Texas Sweet Crude Oil Corp. (TXSC), as "One to Watch", here at the QualityStocks Daily Newsletter.‏

Trading on the Pink Sheets, Texas Sweet Crude Oil Corp. focuses on the exploration and development of oil and related resources. Formerly known as Oxbow Resources Corp. on December 10, 2008, and effective as of the same date, the Company filed Articles of Amendment with the state of Delaware changing the name of the Company to Texas Sweet Crude Oil Corporation. The Company changed their name to Texas Sweet Crude Oil Corp. on December 31, 2008. Founded in 1968, Texas Sweet Crude Oil Corp. has their corporate base in Melbourne, Florida.

A majority of the shareholders of the Company appointed the following Directors and Officers of the Company, on January 13, 2009, effective as of equal date. Wayne Doss, age 56, received appointment as the President, CEO, Secretary, and Director of Texas Sweet Crude Oil Corp. Mr. Doss has served as CFO and CEO for more than 25 years in Public and Private Companies.

Mr. Doss served as CEO of Keller Industries for 9 years, a $250,000,000 Building Products Company with 4,000 employees. For over the past five years, Mr. Doss has consulted and served in various capacities. This includes assisting small public companies with start-ups, interim officer positions, accounting issues, and regulatory filings. He is a graduate from the University of Maryland with degrees in accounting and business management.

In addition, another corporate action became effective on December 31, 2008. A majority of the shareholders resolved to complete a reverse stock split of the Company's outstanding common stock on a ratio of one share for every 1500 shares outstanding.

We have Texas Sweet Crude Oil Corp. (TXSC) ‏ locked on our radar screens as "One to Watch", here at the QualityStocks Daily Newsletter.

Texas Sweet Crude Oil Corp. (TXSC) ‏ closed today at $1.00 on no volume. The 3-month average volume is 178,477,000.

XFormity Technologies, Inc. (XFMY)

Today we choose to highlight XFormity Technologies, Inc. (XFMY), here at the QualityStocks Daily Newsletter.

Headquartered in Dallas, Texas and trading on the OTCBB, XFormity Technologies, Inc. provides a range of technology solutions to multi-unit business operators in the United States. The Company builds solutions that help businesses streamline the flow of information. XFormity's team of software designers and engineers has built a software engine centered on scalable, highly reliable data transfer.

XFormity Technologies, Inc.'s family of products includes their business intelligence solution and balanced scorecard solutions. They designed these for delivering real-time, or near real-time, exception based management and analysis of key performance indicators. The Company offers data integration and analytical tools, and business intelligence packages for multi-unit quick-service restaurant owners and operators.

XFormity designed and built a premium Web Services platform - The Qube™. Through this engine, the Company's clients can integrate their legacy systems and applications as well as smoothly exchange data with partners and clients. Developed with rigorous performance and infinite scalability standards, The Qube™ incorporates highly distinguishable architectural principles to ensure velocity in application development and multi-platform integration. This is with minimal practice adjustment, regardless of a client's current software and hardware environment.

Mission-critical software designed by members of the Company's team finds use today at Bank of America, Sea-Land, Lucent, as well as several Yum! franchises. This is along with use in other high profile organizations. XFormity also has extensive, operational experience to implement and manage resource requirements.

The Company's QSRx software product can provide an organization with the ability to collect information from their partners and customers effectively and quickly. This allows a company to accurately process this information into business intelligence, and integrate the same information into their accounting system. This is possible with the power of the Connected Franchise, which is built upon the QSRx integrated suite of solutions.

XFormity Technologies, Inc. (XFMY) closed Tuesday's trading session at $0.10 up $0.06 or 150.00 percent. Volume was 19,300 for a 3-month average volume of 15,766.

American Home Food Products, Inc. (AHFP)

Today we are reporting on American Home Food Products, Inc. (AHFP), here at the QualityStocks Daily Newsletter.

American Home Food Products, Inc. operates in the specialty cheese market in the United States. The Company markets and distributes a line of specialty, artisanal, and farmstead cheese products. In addition, they offer other related specialty food products under their own ‘Artisanal Premium Cheese’ brand name. American Home Food Products, Inc. is part of the Major Diversified Food industry in the Consumer Goods sector. The Company trades on the OTCBB, and has their corporate headquarters in New York, New York. In August 2007, American Home Food Products, Inc. acquired 100 percent of the ownership interests in Artisanal Premium Cheese.

American Home Food Products, Inc. provides their offerings to upscale restaurants, food wholesalers and retailers, and foodservice distributers. They also provide them directly to consumers through their catalogue and Web site, artisanalcheese.com. The Company, through Artisanal Premium Cheese, is working to grow their market share in the food business. Formerly a building supply-marketing firm, American Home Food Products, Inc. doing business as Artisanal Premium Cheese is now active in the marketing of private-label foods.   

American Home Food Products recently announced that the Company entered the first phase of their retail strategy. This is through placing selections from their line of artisanal cheeses and accompanying condiments in select retail stores in New York City. To support this effort the Company also announced WahlRich Group as their merchandising agency. American Home Food Products is a fulfillment partner with luxury retailers. These include Williams-Sonoma, Neiman-Marcus, Dean & Deluca, Sur la Table, Petrossian, and others. In 2008, the Company opened new markets in Washington, D.C. and Las Vegas, Nevada.

In April of this year, American Home Food Products (Artisanal Premium Cheese) announced results for the third quarter and nine months ended February 28, 2009. For the nine months, ended February 28, 2009, revenues increased 23 percent to $4.6 million from $3.8 million in the same period of 2008. For the third quarter ended February 28, 2009, the Company reported revenues of $2.2 compared to revenues of $2.4 million in the quarter ended February 28, 2008. Gross margin increased slightly to 32.9 percent in the third quarter of fiscal 2009 compared to 32.2 percent in the third quarter of fiscal 2008.

American Home Food Products, Inc. (AHFP) closed today's session at $0.30 up $0.18 or 150.00 percent. Volume was 12,900 for a 3-month average of 3,641.

Averion International Corp. (AVRO)

Today we highlight Averion International Corp. (AVRO), here at the QualityStocks Daily newsletter.

Trading on NASDAQ's OTCBB, Averion International Corp. is an international clinical research organization. Their corporate focus is on providing clinical research services and solutions for the drug development lifecycle.  The Company has expertise in supporting global clinical trials for pharmaceutical, biotechnology, and medical device companies. The Company's well-designed trials span the development lifecycle from "first-in-man" through regulatory approval and beyond. The Company is a clinical research partner for enterprises around the world.

With headquarters in Southborough, Massachusetts, Averion International Corp. evolved through a series of acquisitions. Each of these acquisitions involved the addition of a high-quality clinical research organization (CRO) with major expertise and a proven record of accomplishment.  The Company's acquisition strategy began more robustly in 2005. This was when the Company, then a life sciences staffing business known as IT&E International Group, Inc. (IT&E), acquired their first stand-alone CRO business. 

In 2005, IT&E acquired Millennix, Inc., an Oncology-focused CRO. In 2006, IT&E acquired Averion Inc., a CRO that began operations in 1983 as Boston Biostatistics, Inc., which was co-founded by Philip T. Lavin, Ph.D. and David Schoenfeld, Ph.D.  In 2001, Boston Biostatistics changed their name to Averion Inc., to reflect the Company's change in scope.  In 2006, following the acquisition, the combined Company changed their name to Averion International Corp. and ticker symbol to AVRO.

In 2007, Averion divested the IT&E staffing business segment in order to focus on growing their core clinical research business.  Also in 2007, Averion acquired Hesperion AG, a 10-year old, Switzerland-based CRO having significant experience in supporting global Cardiology, Oncology, and Vaccines trials. Hesperion's acquisition doubled the size of Averion and significantly expanded the Company's worldwide reach in Europe and globally.

Averion International's major therapeutic categories include oncology, cardiology, and medical devices. The Company's main competencies are in product-agency registration support, trial design, site selection, and project management. Their competencies are also in medical and site monitoring, data management, biostatistical analysis, pharmacovigilance, medical writing, metrics development, and full clinical trial management and consulting services.

Averion International Corp. (AVRO) closed today at $0.0190 up $0.0080 or 72.73 percent. Volume was 5,000 for a 3-month average volume of 27,947.

Cephas Holdings Inc. (CEHC)

Today we are highlighting Cephas Holdings Inc. (CEHC) as "One to Watch", here at the QualityStocks Daily Newsletter.

Headquartered in New York, New York, Cephas Holdings Inc. engages in the development and marketing of mobile phone products in the United States. Their products include faceplates, phone accessories, short message service (SMS), and mobile data applications. The company also develops and markets filmed entertainment products related to mixed martial arts and combat sports.

In addition, Cephas develops iPhone applications including games, entertainment products, and information services. The company and their subsidiaries have a record of accomplishment of developing innovative digital products. They have worked with several leading technology enterprises. These include Palm, Motorola, Cingular (now AT&T), and Hewlett Packard. They have also developed products in association with Walt Disney and Visa.

The Company's commitment is to a family of applications that highlight the iPhone and all it can do. This includes Location Based Services, mCommerce, and Social Networking. They are also working on the development of custom games.

In late March of this year, Cephas announced that they recently received acceptance into Apple Computer’s iPhone developer program. The Company is now able to sell applications subject to review and approval on the iTunes App Store directly to consumers. Cephas Holdings Inc. is building on their history of branding mobile applications and devices. Cephas is currently developing iPhone applications under a license from the world heavyweight, mixed martial arts (MMA) champion, Fedor Emelianenko. MMA is one of the fastest growing sports globally.

Cephas Holdings Inc. also recently announced that they released their first mobile application, “Ask the Sheik,” on the Android Market featuring the world famous Iron Sheik. It is available for download to T-Mobile subscribers with an Android phone. In a Question and Answer format, users can ask a question and get a response. Android is the mobile operating system owned by Google. It is available in the United States on the G1 phone from T-Mobile. Cephas plans to develop a marketing campaign using the Sheik in a new series of videos to promote the applications.

We are tracking Cephas Holdings Inc. (CEHC) on our radar screens as "One to Watch", here at the QualityStocks Daily Newsletter.

Cephas Holdings Inc. (CEHC) closed today's trading at $0.0067 on no volume.

Cyberonics Inc. (CYBX)

We are highlighting Cyberonics Inc. (CYBX) today, here at the QualityStocks Daily Newsletter.

Cyberonics, Inc. is a medical technology company with a core expertise in neuromodulation. The Company engages in the design, development, manufacture, and marketing of implantable medical devices that provide vagus nerve stimulation (VNS) therapy. This is for the treatment of refractory epilepsy and treatment-resistant depression.

Trading on the NASDAQ Global Market, Cyberonics Inc. has their headquarters in Houston, Texas. They also have additional offices in Brussels, Belgium. Founded in 1987, Cyberonics, Inc. pioneered the Vagus Nerve Stimulation (VNS Therapy™) System, which is FDA-approved.

The VNS Therapy System uses a surgically implanted medical device that delivers electrical pulsed signals to the vagus nerve in the left side of the neck.  This therapy is effective in significantly reducing the number and/or intensity of seizures in many people suffering from epilepsy. The Company sees the potential for use of the VNS Therapy System in the treatment of other chronic disorders.

Since 1997, more than 32,000 patients globally have received implantation of the VNS Therapy System device. On July 15, 2005, VNS Therapy received approval by the FDA as a long-term adjunctive treatment for treatment-resistant depression. VNS Therapy is also at various levels of study as a potential treatment for chronic disorders, such as anxiety, Alzheimer's, bulimia, and migraines.

Cyberonics, Inc. sells their products through their direct sales force in Europe and the United Kingdom. They also sell through distribution agreements with independent distributors. These distributors are in Canada, Mexico, Australia, and in parts of Central and South America, Asia, the Middle East and Europe.

Last week, Cyberonics, Inc. announced that Bryan D. Olin, Ph.D., joined Cyberonics as Vice President, Quality, effective on May 18, 2009. Dr. Olin will lead all of the Company's quality programs. Dr. Olin joins Cyberonics from Zeltiq Aesthetics, an aesthetics device firm in California. He served there as Senior Director, Quality Assurance, since October 2007. Prior to Zeltiq, Dr. Olin was Executive Director, Failure Analysis, Product Quality Services, and Product Safety with Cordis Corporation, a Johnson & Johnson company.

Cyberonics Inc. (CYBX) closed today's session at $14.03 up $0.42 or 3.09 percent. Volume was 202,472. Their 3-month average volume is 267,680.

The QualityStocks Company Corner

Sector 10 Inc. (SECI)
Kraig Biocraft Labs (KBLB)

Superlattice Power Inc. (SLAT)
Energtek, Inc. (EGTK)

Sector 10 Inc. (SECI)

The QualityStocks Daily Newsletter would like to spotlight Sector 10 Inc. (SECI) Today, Sector 10 Inc. closed trading at $0.21. Their volume today was 31,285 shares for a 3-month average volume of 9,194 shares.

Sector 10, Inc. announced today that John Gargett, who currently heads the Operations Committee on the Board of Directors, has accepted the position of Vice President of Operations and Chief Operations Officer.

Sector 10 Inc. is focused on becoming the world's leading provider of mobile and stationary emergency life response equipment. The company dedicates its efforts to restructuring a fragmented industry with its globally patented Mobile and Stationary Response Unit (”MRU” and “SRU”) product lines and saving lives.

While expanding its global client base, Sector 10 strives to remain rooted in its core competencies and operating principles. The company's strategy is to continue to invest in management and business development, increase efficiency, manage risk and further strengthen our culture. Sector 10 aims to reach corporate profitability and produce a favorable investment environment by establishing a balanced trend of growth and capital management.

The company is perfectly positioned to capitalize on an extremely fragmented industry and dominate its future growth. While billions of tax dollars are wasted in emergency response, little is spent on preparedness. Through Sector 10's pre-deployed solutions, immediate help and safety is available to those who need it most. These systems provide first aid supplies, life saving equipment, occupant tracking through a real-time 3D interface, and emergency communications.

Leading the way at Sector 10 is Pericles DeAvila who serves as the company's CEO, inventor and lead creative thinker. DeAvila is responsible for all strategic, financial and operational aspects of Sector 10 and its associated businesses. DeAvila studied business and construction management in California and also studied at the Institute University of the Azores. He fluently speaks Portuguese, Italian, French, Spanish, as well as English and has entrepreneurial experience nationally and internationally. Disclaimer

Kraig Biocraft Laboratories, Inc. (KBLB)

The QualityStocks Daily Newsletter would like to spotlight Kraig Biocraft Laboratories, Inc. (KBLB) Today, Kraig Biocraft Laboratories, Inc. closed trading at $0.26, which was up $0.09 or 52.94 percent. Their volume today was 109,788 shares for a 3-month average volume of 71,388 shares.

Kraig Biocraft Laboratories, Inc. a biotechnology company, has their focus on developing high performance polymers and technical fibers. The company is utilizing their proprietary genetic engineering technology to develop and produce polymers and protein-based materials, including Spider silk, which may have numerous commercial and consumer applications.

Kraig Biocraft Laboratories, Inc. is working with university scientists and laboratories to create these new polymers that have potentially broad applications in the multi-billion dollar marketplace for high performance polymers. The company sponsors and collaborates on research projects within university genetic engineering laboratories as a means of utilizing the greatest minds in their field.

Spider Silk is one of the strongest fibers produced in nature. The spider's repelling silk is of particular commercial interest since it is both extremely strong and extremely flexible. Although exciting commercial opportunities exist for the natural polymer, there is no known way to produce the fibers in commercial quantity. KraigLabs, in cooperation with two leading universities, has acquired proprietary genetic engineering technology to unlock the mystery.

CEO Kim Thompson leads the company with formal education in the fields of economics and law. With interest in genetic engineering dating back to the 1970s, Mr. Thompson has invented a pending provisional patent application for a number of organic polymers. This patent application has been assigned to benefit Kraig Biocraft and is a central part of the company's efforts in bringing those inventions to the market. Disclaimer

Kraig Biocraft Laboratories, Inc. Blog

News for Kraig Biocraft Laboratories Inc.

Kraig Biocraft Laboratories, Inc. Gears Up to Double the Number of Genetic Insertions Performed and Amgen Exercises Option for Exclusive License to Cytokinetics' Cardiac Contractility Program That Includes CK-1827452.

Kraig Biocraft Laboratories, Inc. Gears Up to Double the Number of Genetic Insertions Performed

Kraig Biocraft Laboratories, Inc. (KBLB.OB) Prepares to Substantially Increase the Number of Genetic Insertions Performed

Superlattice Power Inc. (SLAT)

The QualityStocks Daily Newsletter would like to spotlight Superlattice Power Inc. (SLAT). Today, Superlattice Power Inc. closed trading at $0.54, which was down $0.01 or 1.82 percent. Their volume today was 75,841 shares for a 3-month average volume of 38,419 shares.

Superlattice Power, Inc. is focused on using its resources and efforts to develop and market lithium-powered vehicles and products for use in residential and commercial properties. Using its technology, the company is able to covert scooters, bicycles, mopeds, motorcycles, cars and even homes and businesses into zero-emission, lithium-powered vehicles and facilities.

The company has made considerable progress in advancing its next generation lithium-powered batteries. It is currently developing a new cathode material that can be integrated into a Lithium-ion polymer battery to substantially increase operating voltage range as well as energy density. With the new cathode material, electric vehicles will be able to travel over 200 miles versus the current 120-140 range.

Superlattice Power, Inc. recently announced that its new cathode material can now enter large-scale production. This technological breakthrough will give Superlattice Power the ability to produce all the necessary physical materials at a batch of 100kg each, making it more practical and affordable for the public to switch from gasoline-powered vehicles to emissions-free vehicles powered by Supperlattice's unique technology.

As prices for fossil fuel energy continue to rise, consumers and businesses are seeking an alternative way to power their world. Scientists, analysts and automotive executives have agreed that rising fuel costs and environmental concerns will cause the sales of hybrid and electric vehicles to skyrocket, and Superlattice has positioned itself to take advantage of the anticipated demand. Disclaimer

Superlattice Power, Inc. Daily Blog

Superlattice Power Inc. News:

Superlattice Power, Inc. and Global Giant in Asia Submit Letter of Support to Department of Energy USA for Mass Scale Production, Job Creation, Training and Development of Safe, High Energy Density, Cost Effective, Electric Vehicle Battery Packs

Superlattice Power Inc. Has a Commitment to Partner with Large Asian Lithium-Ion Battery Manufacturer

Superlattice Power, Inc. Acquires Electrochemical Analysis and Cell Manufacturing Equipment for Fortune 500 Company Orders

Energtek, Inc. (EGTK)

The QualityStocks Daily Newsletter would like to spotlight Energtek, Inc. (EGTK). Today Energtek, Inc. closed trading at $0.27, which was up $0.0397 or 17.24 percent. Their volume today was 50,309 shares. Their 3-month average volume is 86,223 shares.

Energtek, Inc. (EGTK) is focused on developing and commercializing Adsorbed Natural Gas (ANG) technology. This technology enables the storage of comparable gas quantities at reduced pressure, dramatically decreasing the capital investment and operational costs of natural gas vehicles. The company recognizes the global markets' demands to diversify energy sources and is working on breakthrough technologies that deliver natural gas to the consumer, even where no gas pipeline and compressing infrastructure exist.

Because natural gas is cheaper, cleaner and available in greater quantities than oil, Energtek believes it is the most practical motor fuel alternative. Natural gas is primarily comprised of methane, which is one of the simplest and most abundant substances found in nature, especially when compared to oil. Taking advantage of natural gas resources located across the globe will also reduce the number of countries forced to import motor fuel, including the USA.

The percentage of Natural Gas Vehicles (NGVs) in many countries is growing rapidly. Today, there are more than 8.7 million NGVs on the road, a number that is growing by more than 30% per year. Even with this robust growth, NGVs still represent only a small percentage of the overall vehicle market. Until now, costly refueling infrastructure, as well as the inconvenience of integrating NG tanks into vehicles, has limited the growth of NGVs. However, by enabling the use of natural gas in places previously impossible, Energtek's proprietary ANG technology promises to greatly expand the NGV market.

CEO Lev Zaidenberg leads the company with extensive experience starting and managing several successful hi-tech companies in Israel, Europe and the USA. Mr. Zaidenberg received a B.Sc. in Applied Mathematics and an MBA from Tel-Aviv University. Professor Yuri Ginzburg serves alongside Zaidenberg with a PhD / D.Sc in Mechanical Engineering and a comprehensive background in the automotive industry. Ginzburg is a specialist in alternative fuel systems and R&D projects management, and has authored 18 patents and over 70 scientific works. Disclaimer

Energtek, Inc. Company Blog

Energtek, Inc. News:

Energtek Inc. Enters Into Agreement for $1.5M Investment in Restricted Stock

The Real Energy Revolution

Energtek's Subsidiary Moregastech India Anticipates Reporting First Revenues in 2009

 

Daily Video
Get the latest market news every weekday at 11am EST with QualityStocks.net anchors Cathy Rankin, Vanessa Ramirez and Jenn Hoffman.
Video.QualityStocks.net


Sponsors of the Day

 

The QualityStocks Public Company Sponsor News

 

QualityStocks By The Numbers Report

 

 

 

About "The QualityStocks Daily"

The QualityStocks Daily Newsletter brings you the latest company News and Profiles featuring the "Top Movers and Shakers" from the Small Cap Market each trading day. QualityStocks is committed to bring our subscribers Public companies in our Newsletter Section "Free of Charge" based on Percentage gained, Momentum, Press, and or Company Fundamentals.

Why do we spotlight companies for Free?

We Want To bring our subscribers the top movers in an unbiased setting.

“Homework Eliminates Mistakes"

Please never invest in a company anyone profiles unless you do the proper research and due diligence.
QualityStocks is compensated by the companies in The QS Company Corner. These companies will include a disclaimer with the amount and term of compensation.
Please consult the QualityStocks Market Basics Section on our site.

Home | Blog | Video | Market Basics | Media | Partners | Clients | About Us | Contact Us | Disclaimer | Unsubscribe
Copyright 2006-2009 QualityStocks 3370 N. Hayden Rd. Suite 123-591 Scottsdale, AZ 85251 480-308-0703